In a significant move to combat the Covid-19 pandemic, the U.S. government agreed to support a controversial proposal to temporarily waive intellectual property rights for vaccines in a bid to increase global supplies of desperately needed doses. The proposal, which was first introduced before the World Trade Organization last fall by South Africa and India, would cover patents, industrial designs, copyrights, and protection of trade secrets.
